Understanding how blood cells called platelets help HIV hide in the brain

Revealing the role of platelets in promoting HIV reservoir seeding and persistence in the CNS-resident myeloid cells

NIH-funded research George Washington University · NIH-11143953

This work explores how platelets might help HIV stay hidden in the brain, even with medication, to find new ways to get rid of the virus.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionGeorge Washington University NIH-funded
Lab location1 site (Washington, United States)
Project IDNIH-11143953 on NIH RePORTER

What this research studies

Even with powerful anti-HIV medicines, the virus can hide in certain parts of the body, like the brain, making a complete cure difficult. This project looks at how tiny blood cells called platelets might play a role in helping HIV create these hidden spots, known as viral reservoirs. By understanding this process, we hope to find new ways to prevent the virus from hiding in the brain. The goal is to develop treatments that could reduce or eliminate these hidden virus reservoirs, bringing us closer to a cure for HIV.

Who could benefit from this research

Good fit: This basic science research is not directly recruiting patients but aims to benefit individuals living with HIV, particularly those concerned about viral reservoirs in the central nervous system.

Not a fit: Patients who do not have HIV or those whose viral reservoirs are not a primary concern for their treatment may not directly benefit from this specific research focus.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that help reduce or eliminate hidden HIV in the brain, potentially moving closer to a cure for people living with HIV.

How similar studies have performed: While anti-retroviral therapies have been highly successful in suppressing HIV, the challenge of eradicating viral reservoirs remains, making this a novel approach to a persistent problem.

Where this research is happening

Washington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.